- MemberSeptember 22, 2021 at 11:04 am
<div>Just read an article, that says CV-19 vaccines protect against all variants.</div>
This article, seems to contradict much of what I’ve been reading – about the narrowly-focused vaccine protections. I’d be very interested, in a knowledgeable person dissecting this article.
- MemberSeptember 30, 2021 at 2:04 am
I have studied a recently published UK hospital data set called “SARS-Cov-2 variants of concern and variants under investigation in England, Technical briefing 20”. The data showed that the Pfizer vaccine is protective of the Delta variant for both the over age 50 population, and the under age 50 population. Protection was measured in terms of hospitalization and mortality.
Now the brain twister was that of the Delta variant infected hospitalized patients, there are more instances of fully vaccinated than not vaccinated. This was seen after removing the supplied age bands. I looked very carefully for calculation mistakes, but there were none. My educated guess is that the average age of a fully vaccinated person is much older than the average age of a not vaccinated person. This could explain what I saw in this data set.
- MemberSeptember 30, 2021 at 11:29 am
Even a B cell antibody response that is not entirely on-target is useful, because it gives body time to generate the more on-target antibodies.
But it still remains the case that the reporting of adverse vaccine events are suppressed by mass media and hospitals alike, so that achieving the “informed” part of the informed consent is hard. A gut call on the adverse event side is all we can do.
- MemberSeptember 30, 2021 at 11:38 am
Thank you for your insights.
I do need to learn more about how the immune systems works, and that will help me navigate the torturous path to the elusive truth.
I will add, that whenever information is suppressed (as is rampant with CV19), there is something nefarious afoot. I hope the Novavax vaccine, proves to be as safe and effective – as it seems to be.